Report cover image

Global Intravenous Antibodies Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 191 Pages
SKU # APRC20362407

Description

Summary

According to APO Research, The global Intravenous Antibodies market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Intravenous Antibodies is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Intravenous Antibodies is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Intravenous Antibodies is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Intravenous Antibodies is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Intravenous Antibodies include Baxter, Sichuan Yuanda Shuyang, Shanghai RAAS, Octapharma, LFB Group, Kedrion, Hualan Bio, Grifols and CSL, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Intravenous Antibodies, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Intravenous Antibodies, also provides the sales of main regions and countries. Of the upcoming market potential for Intravenous Antibodies, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Intravenous Antibodies sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Intravenous Antibodies market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Intravenous Antibodies sales, projected growth trends, production technology, application and end-user industry.

Intravenous Antibodies Segment by Company

Baxter
Sichuan Yuanda Shuyang
Shanghai RAAS
Octapharma
LFB Group
Kedrion
Hualan Bio
Grifols
CSL
CNBG
CBPO
BPL
Biotest
Intravenous Antibodies Segment by Type

IgA
IgD
IgE
IgG
IgM
Intravenous Antibodies Segment by Application

Hospitals
Clinics
Others
Intravenous Antibodies Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Antibodies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Intravenous Antibodies and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Antibodies.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Intravenous Antibodies in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Intravenous Antibodies manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intravenous Antibodies sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Table of Contents

191 Pages
1 Market Overview
1.1 Product Definition
1.2 Intravenous Antibodies Market by Type
1.2.1 Global Intravenous Antibodies Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 IgA
1.2.3 IgD
1.2.4 IgE
1.2.5 IgG
1.2.6 IgM
1.3 Intravenous Antibodies Market by Application
1.3.1 Global Intravenous Antibodies Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Intravenous Antibodies Market Dynamics
2.1 Intravenous Antibodies Industry Trends
2.2 Intravenous Antibodies Industry Drivers
2.3 Intravenous Antibodies Industry Opportunities and Challenges
2.4 Intravenous Antibodies Industry Restraints
3 Global Market Growth Prospects
3.1 Global Intravenous Antibodies Revenue Estimates and Forecasts (2020-2031)
3.2 Global Intravenous Antibodies Revenue by Region
3.2.1 Global Intravenous Antibodies Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Intravenous Antibodies Revenue by Region (2020-2025)
3.2.3 Global Intravenous Antibodies Revenue by Region (2026-2031)
3.2.4 Global Intravenous Antibodies Revenue Market Share by Region (2020-2031)
3.3 Global Intravenous Antibodies Sales Estimates and Forecasts 2020-2031
3.4 Global Intravenous Antibodies Sales by Region
3.4.1 Global Intravenous Antibodies Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Intravenous Antibodies Sales by Region (2020-2025)
3.4.3 Global Intravenous Antibodies Sales by Region (2026-2031)
3.4.4 Global Intravenous Antibodies Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Intravenous Antibodies Revenue by Manufacturers
4.1.1 Global Intravenous Antibodies Revenue by Manufacturers (2020-2025)
4.1.2 Global Intravenous Antibodies Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Intravenous Antibodies Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Intravenous Antibodies Sales by Manufacturers
4.2.1 Global Intravenous Antibodies Sales by Manufacturers (2020-2025)
4.2.2 Global Intravenous Antibodies Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Intravenous Antibodies Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Intravenous Antibodies Sales Price by Manufacturers (2020-2025)
4.4 Global Intravenous Antibodies Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Intravenous Antibodies Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Intravenous Antibodies Manufacturers, Product Type & Application
4.7 Global Intravenous Antibodies Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Intravenous Antibodies Market CR5 and HHI
4.8.2 2024 Intravenous Antibodies Tier 1, Tier 2, and Tier 3
5 Intravenous Antibodies Market by Type
5.1 Global Intravenous Antibodies Revenue by Type
5.1.1 Global Intravenous Antibodies Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Intravenous Antibodies Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Intravenous Antibodies Revenue Market Share by Type (2020-2031)
5.2 Global Intravenous Antibodies Sales by Type
5.2.1 Global Intravenous Antibodies Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Intravenous Antibodies Sales by Type (2020-2031) & (K Units)
5.2.3 Global Intravenous Antibodies Sales Market Share by Type (2020-2031)
5.3 Global Intravenous Antibodies Price by Type
6 Intravenous Antibodies Market by Application
6.1 Global Intravenous Antibodies Revenue by Application
6.1.1 Global Intravenous Antibodies Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Intravenous Antibodies Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Intravenous Antibodies Revenue Market Share by Application (2020-2031)
6.2 Global Intravenous Antibodies Sales by Application
6.2.1 Global Intravenous Antibodies Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Intravenous Antibodies Sales by Application (2020-2031) & (K Units)
6.2.3 Global Intravenous Antibodies Sales Market Share by Application (2020-2031)
6.3 Global Intravenous Antibodies Price by Application
7 Company Profiles
7.1 Baxter
7.1.1 Baxter Comapny Information
7.1.2 Baxter Business Overview
7.1.3 Baxter Intravenous Antibodies Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Baxter Intravenous Antibodies Product Portfolio
7.1.5 Baxter Recent Developments
7.2 Sichuan Yuanda Shuyang
7.2.1 Sichuan Yuanda Shuyang Comapny Information
7.2.2 Sichuan Yuanda Shuyang Business Overview
7.2.3 Sichuan Yuanda Shuyang Intravenous Antibodies Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Sichuan Yuanda Shuyang Intravenous Antibodies Product Portfolio
7.2.5 Sichuan Yuanda Shuyang Recent Developments
7.3 Shanghai RAAS
7.3.1 Shanghai RAAS Comapny Information
7.3.2 Shanghai RAAS Business Overview
7.3.3 Shanghai RAAS Intravenous Antibodies Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Shanghai RAAS Intravenous Antibodies Product Portfolio
7.3.5 Shanghai RAAS Recent Developments
7.4 Octapharma
7.4.1 Octapharma Comapny Information
7.4.2 Octapharma Business Overview
7.4.3 Octapharma Intravenous Antibodies Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Octapharma Intravenous Antibodies Product Portfolio
7.4.5 Octapharma Recent Developments
7.5 LFB Group
7.5.1 LFB Group Comapny Information
7.5.2 LFB Group Business Overview
7.5.3 LFB Group Intravenous Antibodies Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 LFB Group Intravenous Antibodies Product Portfolio
7.5.5 LFB Group Recent Developments
7.6 Kedrion
7.6.1 Kedrion Comapny Information
7.6.2 Kedrion Business Overview
7.6.3 Kedrion Intravenous Antibodies Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Kedrion Intravenous Antibodies Product Portfolio
7.6.5 Kedrion Recent Developments
7.7 Hualan Bio
7.7.1 Hualan Bio Comapny Information
7.7.2 Hualan Bio Business Overview
7.7.3 Hualan Bio Intravenous Antibodies Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Hualan Bio Intravenous Antibodies Product Portfolio
7.7.5 Hualan Bio Recent Developments
7.8 Grifols
7.8.1 Grifols Comapny Information
7.8.2 Grifols Business Overview
7.8.3 Grifols Intravenous Antibodies Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Grifols Intravenous Antibodies Product Portfolio
7.8.5 Grifols Recent Developments
7.9 CSL
7.9.1 CSL Comapny Information
7.9.2 CSL Business Overview
7.9.3 CSL Intravenous Antibodies Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 CSL Intravenous Antibodies Product Portfolio
7.9.5 CSL Recent Developments
7.10 CNBG
7.10.1 CNBG Comapny Information
7.10.2 CNBG Business Overview
7.10.3 CNBG Intravenous Antibodies Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 CNBG Intravenous Antibodies Product Portfolio
7.10.5 CNBG Recent Developments
7.11 CBPO
7.11.1 CBPO Comapny Information
7.11.2 CBPO Business Overview
7.11.3 CBPO Intravenous Antibodies Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 CBPO Intravenous Antibodies Product Portfolio
7.11.5 CBPO Recent Developments
7.12 BPL
7.12.1 BPL Comapny Information
7.12.2 BPL Business Overview
7.12.3 BPL Intravenous Antibodies Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 BPL Intravenous Antibodies Product Portfolio
7.12.5 BPL Recent Developments
7.13 Biotest
7.13.1 Biotest Comapny Information
7.13.2 Biotest Business Overview
7.13.3 Biotest Intravenous Antibodies Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Biotest Intravenous Antibodies Product Portfolio
7.13.5 Biotest Recent Developments
8 North America
8.1 North America Intravenous Antibodies Market Size by Type
8.1.1 North America Intravenous Antibodies Revenue by Type (2020-2031)
8.1.2 North America Intravenous Antibodies Sales by Type (2020-2031)
8.1.3 North America Intravenous Antibodies Price by Type (2020-2031)
8.2 North America Intravenous Antibodies Market Size by Application
8.2.1 North America Intravenous Antibodies Revenue by Application (2020-2031)
8.2.2 North America Intravenous Antibodies Sales by Application (2020-2031)
8.2.3 North America Intravenous Antibodies Price by Application (2020-2031)
8.3 North America Intravenous Antibodies Market Size by Country
8.3.1 North America Intravenous Antibodies Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Intravenous Antibodies Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Intravenous Antibodies Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Intravenous Antibodies Market Size by Type
9.1.1 Europe Intravenous Antibodies Revenue by Type (2020-2031)
9.1.2 Europe Intravenous Antibodies Sales by Type (2020-2031)
9.1.3 Europe Intravenous Antibodies Price by Type (2020-2031)
9.2 Europe Intravenous Antibodies Market Size by Application
9.2.1 Europe Intravenous Antibodies Revenue by Application (2020-2031)
9.2.2 Europe Intravenous Antibodies Sales by Application (2020-2031)
9.2.3 Europe Intravenous Antibodies Price by Application (2020-2031)
9.3 Europe Intravenous Antibodies Market Size by Country
9.3.1 Europe Intravenous Antibodies Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Intravenous Antibodies Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Intravenous Antibodies Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Netherlands
10 China
10.1 China Intravenous Antibodies Market Size by Type
10.1.1 China Intravenous Antibodies Revenue by Type (2020-2031)
10.1.2 China Intravenous Antibodies Sales by Type (2020-2031)
10.1.3 China Intravenous Antibodies Price by Type (2020-2031)
10.2 China Intravenous Antibodies Market Size by Application
10.2.1 China Intravenous Antibodies Revenue by Application (2020-2031)
10.2.2 China Intravenous Antibodies Sales by Application (2020-2031)
10.2.3 China Intravenous Antibodies Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Intravenous Antibodies Market Size by Type
11.1.1 Asia Intravenous Antibodies Revenue by Type (2020-2031)
11.1.2 Asia Intravenous Antibodies Sales by Type (2020-2031)
11.1.3 Asia Intravenous Antibodies Price by Type (2020-2031)
11.2 Asia Intravenous Antibodies Market Size by Application
11.2.1 Asia Intravenous Antibodies Revenue by Application (2020-2031)
11.2.2 Asia Intravenous Antibodies Sales by Application (2020-2031)
11.2.3 Asia Intravenous Antibodies Price by Application (2020-2031)
11.3 Asia Intravenous Antibodies Market Size by Country
11.3.1 Asia Intravenous Antibodies Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Intravenous Antibodies Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Intravenous Antibodies Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Intravenous Antibodies Market Size by Type
12.1.1 SAMEA Intravenous Antibodies Revenue by Type (2020-2031)
12.1.2 SAMEA Intravenous Antibodies Sales by Type (2020-2031)
12.1.3 SAMEA Intravenous Antibodies Price by Type (2020-2031)
12.2 SAMEA Intravenous Antibodies Market Size by Application
12.2.1 SAMEA Intravenous Antibodies Revenue by Application (2020-2031)
12.2.2 SAMEA Intravenous Antibodies Sales by Application (2020-2031)
12.2.3 SAMEA Intravenous Antibodies Price by Application (2020-2031)
12.3 SAMEA Intravenous Antibodies Market Size by Country
12.3.1 SAMEA Intravenous Antibodies Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Intravenous Antibodies Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Intravenous Antibodies Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Intravenous Antibodies Value Chain Analysis
13.1.1 Intravenous Antibodies Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Intravenous Antibodies Production Mode & Process
13.2 Intravenous Antibodies Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Intravenous Antibodies Distributors
13.2.3 Intravenous Antibodies Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.